Iris Dekker

1.0k citations

22 papers · 657 · h-index 15

Impact in

Pathology and Forensic Medicine top 2%
- Multiple Sclerosis Research Studies
Neurology top 10%
- Neurological disorders and treatments
- Peripheral Neuropathies and Disorders
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms

Papers in

Pathology and Forensic Medicine 17
- Multiple Sclerosis Research Studies 16
- Systemic Sclerosis and Related Diseases 1
Neurology 2
- Neurological disorders and treatments 1

Co-authors: Bernard M.J. Uitdehaag (16 shared papers)Frederik Barkhof (14 shared papers)Jeroen J.G. Geurts (11 shared papers)A. J. C. Eijlers (9 shared papers)Menno M. Schoonheim (10 shared papers)Mike P. Wattjes (10 shared papers)Hanneke E. Hulst (6 shared papers)Kim Meijer (3 shared papers)
Journals: Multiple Sclerosis Journal (6 papers)Neurology (4 papers)NeuroImage Clinical (3 papers)Brain Communications (2 papers)European Journal of Neurology (1 paper)
Partner nations: Netherlands United Kingdom Germany

In The Last Decade

Iris Dekker

22 papers receiving 653 citations

Peers

Countries citing papers authored by Iris Dekker

Since Specialization

Citations

This map shows the geographic impact of Iris Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Dekker more than expected).

Fields of papers citing papers by Iris Dekker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Dekker. The network helps show where Iris Dekker may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Dekker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Dekker Line = papers co-authored together Iris Dekker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study Brain ·A. J. C. Eijlers, Quinten van Geest, Iris Dekker, Martijn D. Steenwijk, Kim Meijer, Hanneke E. Hulst, Frederik Barkhof, Bernard M.J. Uitdehaag, Menno M. Schoonheim, Jeroen J.G. Geurts	2018	169
2	Neuropsychological outcome after deep brain stimulation for Parkinson disease Neurology ·Vincent J.J. Odekerken, Judith A. Boel, Gert J. Geurtsen, Ben Schmand, Iris Dekker, Rob J. de Haan, P. Richard Schuurman, Rob M.A. de Bie, (unknown), Teus van Laar, Michiel J. Staal, Arne Mosch, C.F.E. Hoffmann, Peter C.G. Nijssen, Guus Beute, Jeroen P.P. van Vugt, W.P.M. Mathieu, Maria Fiorella Contarino, Marieke S.J. Mink, Lo J. Bour, Pepijn van den Munckhof, (unknown), (unknown), (unknown)	2015	68
3	Cortical atrophy accelerates as cognitive decline worsens in multiple sclerosis Neurology ·A. J. C. Eijlers, Iris Dekker, Martijn D. Steenwijk, Kim Meijer, Hanneke E. Hulst, Petra J. W. Pouwels, Bernard M.J. Uitdehaag, Frederik Barkhof, Hugo Vrenken, Menno M. Schoonheim, Jeroen J.G. Geurts	2019	62
4	Predicting clinical progression in multiple sclerosis after 6 and 12 years European Journal of Neurology ·Iris Dekker, A. J. C. Eijlers, Veronica Popescu, Lisanne J. Balk, Hugo Vrenken, Mike P. Wattjes, Bernard M.J. Uitdehaag, Joep Killestein, Jeroen J.G. Geurts, Frederik Barkhof, Menno M. Schoonheim	2019	46
5	Molecular cloning of the gene for the E1α subunit of the pyruvate dehydrogenase complex from Saccharomyces cerevisiae European Journal of Biochemistry ·H. Yde Steensma, Lennart Holterman, Iris Dekker, Cees A. van Sluis, Thibaut J. Wenzel	1990	35
6	Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability? Multiple Sclerosis Journal ·Iris Dekker, Madeleine H Sombekke, Lisanne J. Balk, Bastiaan Moraal, Jeroen J.G. Geurts, Frederik Barkhof, Bernard M.J. Uitdehaag, Joep Killestein, Mike P. Wattjes	2019	30
7	Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and Variants Neuroimaging Clinics of North America ·Iris Dekker, Mike P. Wattjes	2017	28
8	Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis Neurology ·Marijn Huiskamp, A. J. C. Eijlers, Tommy A.A. Broeders, Jasmin Pasteuning, Iris Dekker, Bernard M.J. Uitdehaag, Frederik Barkhof, Alle Meije Wink, Jeroen J.G. Geurts, Hanneke E. Hulst, Menno M. Schoonheim	2021	26
9	The sequence of structural, functional and cognitive changes in multiple sclerosis NeuroImage Clinical ·Iris Dekker, Menno M. Schoonheim, Vikram Venkatraghavan, A. J. C. Eijlers, Iman Brouwer, Esther E. Bron, Stefan Klein, Mike P. Wattjes, Alle Meije Wink, Jeroen J.G. Geurts, Bernard M.J. Uitdehaag, Neil P. Oxtoby, Daniel C. Alexander, Hugo Vrenken, Joep Killestein, Frederik Barkhof, Viktor Wottschel	2020	25
10	Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects NeuroImage Clinical ·Merlin M. Weeda, S.M. Middelkoop, Martijn D. Steenwijk, Marita Daams, Houshang Amiri, Iman Brouwer, Joep Killestein, Bernard M.J. Uitdehaag, Iris Dekker, Carsten Lukas, Barbara Bellenberg, Frederik Barkhof, Petra J. W. Pouwels, Hugo Vrenken	2019	25
11	The natalizumab wearing-off effect Neurology ·Zoé L. E. van Kempen, Djoeke Doesburg, Iris Dekker, Birgit I. Lissenberg‐Witte, Annick de Vries, Iris Claessen, Anja ten Brinke, Theo Rispens, Joep Killestein	2019	25
12	Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients Multiple Sclerosis Journal ·Cyra E Leurs, Zoé L. E. van Kempen, Iris Dekker, Lisanne J. Balk, Mike P. Wattjes, Theo Rispens, Bernard M.J. Uitdehaag, Joep Killestein	2017	19
13	Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis Multiple Sclerosis Journal ·Zoë YGJ van Lierop, Luuk Wieske, Marleen J.A. Koel‐Simmelink, Madhurima Chatterjee, Iris Dekker, Cyra E Leurs, Eline A.J. Willemse, Bastiaan Moraal, Frederik Barkhof, Filip Eftimov, Bernard M.J. Uitdehaag, Joep Killestein, Charlotte E. Teunissen	2021	16
14	Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis Multiple Sclerosis Journal ·Iris Dekker, Madeleine H Sombekke, Birgit I. Lissenberg‐Witte, Jeroen J.G. Geurts, Frederik Barkhof, Bernard M.J. Uitdehaag, Joep Killestein, Mike P. Wattjes	2017	15
15	Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis Multiple Sclerosis Journal ·Myrte Strik, Declan Chard, Iris Dekker, Kim Meijer, A. J. C. Eijlers, Matteo Pardini, Bernard M.J. Uitdehaag, Scott Kolbe, Jeroen J.G. Geurts, Menno M. Schoonheim	2020	15
16	A more unstable resting-state functional network in cognitively declining multiple sclerosis Brain Communications ·Tommy A.A. Broeders, Linda Douw, A. J. C. Eijlers, Iris Dekker, Bernard M.J. Uitdehaag, Frederik Barkhof, Hanneke E. Hulst, Christiaan H. Vinkers, Jeroen J.G. Geurts, Menno M. Schoonheim	2022	14
17	Disease activity following pregnancy-related discontinuation of natalizumab in MS Neurology Neuroimmunology & Neuroinflammation ·Iris Kleerekooper, Zoé L. E. van Kempen, Cyra E Leurs, Iris Dekker, Theo Rispens, Birgit I. Lissenberg‐Witte, Caspar E.P. van Munster, Brigit A. de Jong, Bob W. van Oosten, Bernard M.J. Uitdehaag, Mike P. Wattjes, Joep Killestein	2017	13
18	Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab Multiple Sclerosis and Related Disorders ·Iris Dekker, Cyra E Leurs, Marloes Hagens, Zoé L. E. van Kempen, Iris Kleerekooper, Birgit I. Lissenberg‐Witte, Frederik Barkhof, Bernard M.J. Uitdehaag, Lisanne J. Balk, Mike P. Wattjes, Joep Killestein	2019	13
19	Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis Multiple Sclerosis Journal ·Myrte Strik, A. J. C. Eijlers, Iris Dekker, Tommy A.A. Broeders, Linda Douw, Joep Killestein, Scott Kolbe, Jeroen J.G. Geurts, Menno M. Schoonheim	2022	7
20	Longitudinal fibre-specific white matter damage predicts cognitive decline in multiple sclerosis Brain Communications ·Ismail Koubiyr, Eva A. Krijnen, A. J. C. Eijlers, Iris Dekker, Hanneke E. Hulst, Bernard M.J. Uitdehaag, Frederik Barkhof, Jeroen J.G. Geurts, Menno M. Schoonheim	2023	3

About Iris Dekker

Iris Dekker is a scholar working on Pathology and Forensic Medicine, Neurology, Cognitive Neuroscience, Oncology and Surgery, having authored 22 papers that have together received 657 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (16 papers), Polyomavirus and related diseases (2 papers), Functional Brain Connectivity Studies (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Neurological disorders and treatments (1 paper), Biochemical Acid Research Studies (1 paper), Mental Health Research Topics (1 paper) and Advanced Neuroimaging Techniques and Applications (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (452 citations), Neurology (149 citations), Neurology (51 citations), Developmental Neuroscience (20 citations) and Rheumatology (35 citations). Iris Dekker has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Bernard M.J. Uitdehaag, Frederik Barkhof, Jeroen J.G. Geurts, A. J. C. Eijlers, Menno M. Schoonheim, Mike P. Wattjes, Hanneke E. Hulst, Kim Meijer, Joep Killestein and Martijn D. Steenwijk. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, NeuroImage Clinical, Brain Communications and European Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Iris Dekker

Impact in

Papers in i

In The Last Decade

Iris Dekker

Peers

Countries citing papers authored by Iris Dekker

Fields of papers citing papers by Iris Dekker

All Works

About Iris Dekker

Explore authors with similar magnitude of impact

Papers in